Debra Patt

10.3k citations
88 papers · 7.6k · 5 hit papers · h-index 34

Impact in

  • Oncology top 0.5%
    • Cancer Immunotherapy and Biomarkers
    • HER2/EGFR in Cancer Research
    • COVID-19 and healthcare impacts
    • PARP inhibition in cancer therapy
    • Breast Cancer Treatment Studies

Papers in

Debra Patt

84 papers receiving 7.4k citations

Debra Patt's Hit Papers

Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study 2021 · 275 citations
2750+5+10Years since publication50010001.5k

Peers

Debra Patt
Comparison fields: 5 of 93
  • Oncology 2.5k
  • Cancer Research 841
  • Pulmonary and Respiratory Medicine 950
  • Modeling and Simulation 98
  • Health Informatics 40
Replace Hatem Hussein Soliman with:
Hatem Hussein Soliman United States
Fabrizio Stracci Italy
Anne Caroline Armstrong United Kingdom
Miriam Koopman Netherlands
Joseph Gligorov France
Kevin S. Hughes United States
John Broggio United Kingdom
Constance Cirrincione United States
Fortunato Bianconi Italy
Jeffrey S. Abrams United States
Debra Patt relative to Hatem Hussein Soliman United States Hatem Hussein Soliman's profile →
Citations per field
00.5×2×3×4×4.7×
Hatem Hussein Soliman · 1×
Citations per year

Countries citing papers authored by Debra Patt

Since Specialization
Citations

This map shows the geographic impact of Debra Patt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debra Patt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debra Patt more than expected).

Fields of papers citing papers by Debra Patt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Debra Patt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debra Patt. The network helps show where Debra Patt may publish in the future.

Co-authors

The 25 scholars most cited alongside Debra Patt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Debra Patt Line = papers co-authored together Debra Patt links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 88 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma
Hit paper breakdown →
20151740
2
Iniparib plus Chemotherapy in Metastatic Triple-Negative Breast Cancer
Hit paper breakdown →
2011678
3
MONARCH 1, A Phase II Study of Abemaciclib, a CDK4 and CDK6 Inhibitor, as a Single Agent, in Patients with Refractory HR+/HER2− Metastatic Breast Cancer
Hit paper breakdown →
2017560
4 2017469
5
Impact of COVID-19 on Cancer Care: How the Pandemic Is Delaying Cancer Diagnosis and Treatment for American Seniors
Hit paper breakdown →
2020466
6 2014287
7
Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study
Hit paper breakdown →
2021275
8 2007273
9 2005183
10 2020171
11 2018150
12 2014149
13 2022138
14 2019120
15 2021113
16 2007112
17 2015111
18 202196
19 201192
20 202292

About Debra Patt

Debra Patt is a scholar working on Oncology, Health Information Management, Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Cancer Research, having authored 88 papers that have together received 7.6k indexed citations. Recurring topics across this work include MRI in cancer diagnosis (9 papers), HER2/EGFR in Cancer Research (8 papers), Advanced Breast Cancer Therapies (7 papers), Electronic Health Records Systems (4 papers), Telemedicine and Telehealth Implementation (4 papers), Cancer Treatment and Pharmacology (3 papers), Brain Metastases and Treatment (3 papers) and Cancer survivorship and care (3 papers). The work is most often cited by research in Oncology (2.5k citations), Cancer Research (841 citations), Pulmonary and Respiratory Medicine (950 citations), Modeling and Simulation (98 citations) and Health Informatics (40 citations). Debra Patt has collaborated with scholars based in United States, France and Spain. Frequent co-authors include Sharon Hermes Giordano, Frank Stephen Hodi, Dirk Schadendorf, Kim Allyson Margolin, Omid Hamid, Tai‐Tsang Chen, Jedd D. Wolchok, Jeffrey S. Weber, Caroline Robert and Joyce O’Shaughnessy. Their work appears in journals such as Journal of Clinical Oncology, American Society of Clinical Oncology Educational Book, JCO Clinical Cancer Informatics, Journal of Oncology Practice and JCO Oncology Practice.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact